North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022

North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year end of 2022.
 
 Long–term Growth Projection:
 
 • Number of diabetes population in United States will increase to more than 33 Million by the year end of 2022
 
 • In 2016, there were more than 5,00,000 insulin pump users in United States
 
 • Canada Insulin Pump market generated more than US$ 160 Million in 2016
 
 • The US is the major market share holder for the North America Insulin Pump Market
 
 Increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle–compatible treatment options and technological advancement in insulin pump devices are the key factors driving the growth of the North America Insulin Pump Market. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.
 
 “North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022” provides a deep and thorough evaluation of the North America Insulin Pump Market. The report provides an in–depth analysis of the type 1, type 2, newly diagnosed type 1 diabetes and overall diabetes population of all the three countries covered in the report. It provides an essential insights of insulin pump users in terms of volume in detail for latest trends, outlook and opportunities in all the three countries covered in the report.
 
 Market outlook in value terms has been analyzed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Key trends in terms of collaborations, partnerships and licensing agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the North America Insulin Pump Market.
 
 The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation, Tandem Diabetes Care, Microport and Sooil Development. The major market players are evaluated on various parameters such as company overview, product outlook, latest development and trends and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.
 
 Key Topics Covered in the Report
 
 • United States, Canada & Mexico Diabetes Population Analysis (2011 – 2022)
 • North America Insulin Pump Users & Market Prospect & Growth (2011 – 2022)
 • North America Insulin Pump Users & Market Share – By Countries (2011 – 2022)
 • North America Insulin Pump Market Analysis – By Countries (2011– 2022)
 • United States Insulin Pump Users and Market Analysis (2011 – 2022)
 • United States Insulin Pump Preferred Brand – By Product
 • Canada Insulin Pump Users and Market Analysis (2011 – 2022)
 • Mexico Insulin Pump Users and Market Analysis (2011 – 2022)
 • North America (All 3 Countries) Insulin Pump Reimbursement & Regulation System
 • North America Insulin Pump Market – Major Deal Types
 • Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
 • Key Drivers and Inhibitors of the North America Insulin Pump Market
 • Key Companies Analysis
 
 Major Countries Covered in This Report:
 
 • United States
 • Canada
 • Mexico
 
 Major Companies Covered in This Report:
 
 • Insulet Corporation
 • Medtronic
 • Roche
 • Animas Corporation and
 • Tandem Diabetes Care
 • Microport
 • Sooil Development

 1. Executive Summary
 
 2. North America Diabetes Population (2011 – 2022): An Analysis
 2.1 United States
 2.1.1 Overall Diabetes Population
 2.1.1.1 Type 1 Diabetes
 2.1.1.2 Type 2 Diabetes
 2.1.1.3 Newly Diagnosed Type 1 Diabetes
 2.2 Canada
 2.2.1 Overall Diabetes Population
 2.2.1.1 Type 1 Diabetes
 2.2.1.2 Type 2 Diabetes
 2.2.1.3 Newly Diagnosed Type 1 Diabetes
 2.3 Mexico
 2.3.1 Overall Diabetes Population
 2.3.1.1 Type 1 Diabetes
 2.3.1.2 Type 2 Diabetes
 2.3.1.3 Newly Diagnosed Type 1 Diabetes
 
 3. North America Insulin Pump Market Prospect & Growth (2011 – 2022)
 3.1 Insulin Pump Users
 3.2 Insulin Pump Market
 
 4. North America Insulin Pump Market Share – By Countries (2011 – 2022)
 4.1 Insulin Pump Users Share
 4.2 Insulin Pump Market Share
 
 5. North America Insulin Pump Market Analysis – By Countries (2011– 2022)
 5.1 United States
 5.1.1 Insulin Pump Users
 5.1.2 Insulin Pump Market
 5.1.3 United States Insulin Pump Preferred Brand – By Product
 5.1.3.1 Pediatric
 5.1.3.2 Adult
 5.2 Canada
 5.2.1 Insulin Pump Users
 5.2.2 Insulin Pump Market
 5.3 Mexico
 5.3.1 Insulin Pump Users
 5.3.2 Insulin Pump Market
 
 6. Key Drivers and Inhibitors of the North America Insulin Pump Market
 6.1 Market Drivers
 6.2 Inhibitors
 
 7. North America Insulin Pump Market: Reimbursement & Regulation System
 7.1 United States
 7.1.1 Reimbursement System
 7.1.2 Regulation System
 7.2 Canada
 7.2.1 Reimbursement System
 7.2.2 Regulation System
 7.3 Mexico
 7.3.1 Regulation System
 
 8. North America Insulin Pump Market – Major Deal Types
 8.1 Insulin Pump Market – Collaboration Deals
 8.2 Insulin Pump Market – Licensing Agreement
 8.3 Insulin Pump Market – Exclusive Agreement
 8.4 Insulin Pump Market – Partnerships Deals
 
 9. Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
 9.1 Year 2016
 9.2 Year 2015
 9.3 Year 2014
 9.4 Year 2013
 9.5 Year 2012
 
 10. Key Companies Analysis
 10.1 Medtronic
 10.1.1 Business Overview
 10.1.2 Insulin Pump – Product Details
 10.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
 10.1.4 Insulin Pump – Latest Development & Trends
 10.2 Tandem Diabetes Care
 10.2.1 Business Overview
 10.2.2 Insulin Pump – Product Details
 10.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022)
 10.2.4 Insulin Pump – Latest Development & Trends
 10.3 Insulet Corporation
 10.3.1 Business Overview
 10.3.2 Insulin Pump – Product Details
 10.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022)
 10.3.4 Insulin Pump – Latest Development & Trends
 10.4 Animas Corporation (Johnson & Johnson)
 10.4.1 Business Overview
 10.4.2 Insulin Pump – Product Details
 10.4.3 Johnson & Johnson – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
 10.4.4 Insulin Pump – Latest Development & Trends
 10.5 Roche
 10.5.1 Business Overview
 10.5.2 Insulin Pump – Product Details
 10.5.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022)
 10.5.4 Insulin Pump – Latest Development & Trends
 10.6 Microport
 10.6.1 Business Overview
 10.6.2 Insulin Pump – Product Details
 10.6.3 Microport – Global Diabetes Sales Analysis & Forecast (2013 – 2022)
 10.6.4 Insulin Pump – Latest Development & Trends
 10.7 Sooil Development
 10.7.1 Business Overview
 10.7.2 Insulin Pump – Product Details
 10.7.3 Insulin Pump – Latest Development & Trends
  

List Of Tables

 Table 4–1: North America – Insulin Pump Users Share (Percent), 2011 – 2016
 Table 4–2: North America – Forecast for Insulin Pump Users Share (Percent), 2017 – 2022
 Table 4–3: North America – Insulin Pump Market Share (Percent), 2011 – 2016
 Table 4–4: North America – Forecast for Insulin Pump Market Share (Percent), 2017 – 2022
 Table 6–1: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
 Table 8–1: Collaboration Deals in Insulin Pump Market, 2009 – 2016
 Table 8–2: Licensing Agreement in Insulin Pump Market, 2015 – 2016
 Table 8–3: Exclusive Agreement in Insulin Pump Market, 2011 – 2017
 Table 8–4: Partnerships Deals in Insulin Pump Market, 2010 – 2017

List Of Figures

 Figure 2–1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
 Figure 2–2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
 Figure 2–3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
 Figure 2–4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
 Figure 2–5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
 Figure 2–6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
 Figure 2–7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
 Figure 2–8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
 Figure 2–9: Canada – Overall Diabetes Population (Thousand), 2011 – 2016
 Figure 2–10: Canada – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
 Figure 2–11: Canada – Type 1 Diabetes Population (Thousand), 2011 – 2016
 Figure 2–12: Canada – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
 Figure 2–13: Canada – Type 2 Diabetes Population (Thousand), 2011 – 2016
 Figure 2–14: Canada – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
 Figure 2–15: Canada – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
 Figure 2–16: Canada – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
 Figure 2–17: Mexico – Overall Diabetes Population (Thousand), 2011 – 2016
 Figure 2–18: Mexico – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
 Figure 2–19: Mexico – Type 1 Diabetes Population (Thousand), 2011 – 2016
 Figure 2–20: Mexico – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
 Figure 2–21: Mexico – Type 2 Diabetes Population (Thousand), 2011 – 2016
 Figure 2–22: Mexico – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
 Figure 2–23: Mexico – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
 Figure 2–24: Mexico – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
 Figure 3–1: North America – Insulin Pump Users (Number), 2011 – 2016
 Figure 3–2: North America – Forecast for Insulin Pump Users (Number), 2017 – 2022
 Figure 3–3: North America – Insulin Pump Market (Million US$), 2011 – 2016
 Figure 3–4: North America – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
 Figure 5–1: United States – Insulin Pump Users (Number), 2011 – 2016
 Figure 5–2: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
 Figure 5–3: United States – Insulin Pump Market (Million US$), 2011 – 2016
 Figure 5–4: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
 Figure 5–5: United States – Pediatric Insulin Pump Preference by Product(Percent),2016
 Figure 5–6: United States – Adult Insulin Pump Preference by Product(Percent),2016
 Figure 5–7: Canada – Insulin Pump Users (Number), 2011 – 2016
 Figure 5–8: Canada – Forecast for Insulin Pump Users (Number), 2017 – 2022
 Figure 5–9: Canada – Insulin Pump Market (Million US$), 2011 – 2016
 Figure 5–10: Canada – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
 Figure 5–11: Mexico – Insulin Pump Users (Number), 2011 – 2016
 Figure 5–12: Mexico – Forecast for Insulin Pump Users (Number), 2017 – 2022
 Figure 5–13: Mexico – Insulin Pump Market (Million US$), 2011 – 2016
 Figure 5–14: Mexico – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
 Figure 10–1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
 Figure 10–2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
 Figure 10–3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
 Figure 10–4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
 Figure 10–5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
 Figure 10–6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
 Figure 10–7: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2013 – 2016
 Figure 10–8: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2017 – 2022
 Figure 10–9: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
 Figure 10–10: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022
 Figure 10–11: Microport – Diabetes Sales Analysis (Million US$),2013 – 2016
 Figure 10–12: Microport – Forecast for Diabetes Sales Analysis (Million US$),2017 – 2022
  
 Companies Mentioned
 
 Medtronic,
 Tandem Diabetes Care,
 Insulet Corporation,
 Animas Corporation,
 Roche,
 Microport,
 Sooil Development 

Fill The Form For Sample Request

There is no Reviews available